
LAVA Therapeutics NV
NASDAQ:LVTX

LAVA Therapeutics NV?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.91
3.37
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does LAVA Therapeutics NV hold over its rivals?
What risks and challenges
does LAVA Therapeutics NV face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of LAVA Therapeutics NV.
Provide an overview of the primary business activities
of LAVA Therapeutics NV.
What unique competitive advantages
does LAVA Therapeutics NV hold over its rivals?
What risks and challenges
does LAVA Therapeutics NV face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for LAVA Therapeutics NV.
Provide P/S
for LAVA Therapeutics NV.
Provide P/E
for LAVA Therapeutics NV.
Provide P/OCF
for LAVA Therapeutics NV.
Provide P/FCFE
for LAVA Therapeutics NV.
Provide P/B
for LAVA Therapeutics NV.
Provide EV/S
for LAVA Therapeutics NV.
Provide EV/GP
for LAVA Therapeutics NV.
Provide EV/EBITDA
for LAVA Therapeutics NV.
Provide EV/EBIT
for LAVA Therapeutics NV.
Provide EV/OCF
for LAVA Therapeutics NV.
Provide EV/FCFF
for LAVA Therapeutics NV.
Provide EV/IC
for LAVA Therapeutics NV.
Show me price targets
for LAVA Therapeutics NV made by professional analysts.
What are the Revenue projections
for LAVA Therapeutics NV?
How accurate were the past Revenue estimates
for LAVA Therapeutics NV?
What are the Net Income projections
for LAVA Therapeutics NV?
How accurate were the past Net Income estimates
for LAVA Therapeutics NV?
What are the EPS projections
for LAVA Therapeutics NV?
How accurate were the past EPS estimates
for LAVA Therapeutics NV?
What are the EBIT projections
for LAVA Therapeutics NV?
How accurate were the past EBIT estimates
for LAVA Therapeutics NV?
Compare the revenue forecasts
for LAVA Therapeutics NV with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of LAVA Therapeutics NV and its key competitors using the latest financial data.
Compare historical revenue growth rates
of LAVA Therapeutics NV against its competitors.
Analyze the profit margins
(gross, operating, and net) of LAVA Therapeutics NV compared to its peers.
Compare the P/E ratios
of LAVA Therapeutics NV against its peers.
Discuss the investment returns and shareholder value creation
comparing LAVA Therapeutics NV with its peers.
Analyze the financial leverage
of LAVA Therapeutics NV compared to its main competitors.
Show all profitability ratios
for LAVA Therapeutics NV.
Provide ROE
for LAVA Therapeutics NV.
Provide ROA
for LAVA Therapeutics NV.
Provide ROIC
for LAVA Therapeutics NV.
Provide ROCE
for LAVA Therapeutics NV.
Provide Gross Margin
for LAVA Therapeutics NV.
Provide Operating Margin
for LAVA Therapeutics NV.
Provide Net Margin
for LAVA Therapeutics NV.
Provide FCF Margin
for LAVA Therapeutics NV.
Show all solvency ratios
for LAVA Therapeutics NV.
Provide D/E Ratio
for LAVA Therapeutics NV.
Provide D/A Ratio
for LAVA Therapeutics NV.
Provide Interest Coverage Ratio
for LAVA Therapeutics NV.
Provide Altman Z-Score Ratio
for LAVA Therapeutics NV.
Provide Quick Ratio
for LAVA Therapeutics NV.
Provide Current Ratio
for LAVA Therapeutics NV.
Provide Cash Ratio
for LAVA Therapeutics NV.
What is the historical Revenue growth
over the last 5 years for LAVA Therapeutics NV?
What is the historical Net Income growth
over the last 5 years for LAVA Therapeutics NV?
What is the current Free Cash Flow
of LAVA Therapeutics NV?
Discuss the annual earnings per share (EPS)
trend over the past five years for LAVA Therapeutics NV.
P/S
Price to Sales
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
Market Cap | P/S | ||||
---|---|---|---|---|---|
NL |
![]() |
LAVA Therapeutics NV
NASDAQ:LVTX
|
33.4m USD | 4.5 | |
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
6T USD | 36 662 780 |
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
369.9B USD | 6.6 |
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
167.3B USD | 5 |
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
139.6B USD | 4.9 |
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
124.6B USD | 11.3 |
|
US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 1 921.5 |
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
121B AUD | 5 |
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
69.5B USD | 4.9 |
|
US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 18.5 |
|
NL |
![]() |
argenx SE
XBRU:ARGX
|
32.3B EUR | 16 |
|
Revenue Growth | P/S to Growth | |||||
---|---|---|---|---|---|---|
NL |
![]() |
LAVA Therapeutics NV
NASDAQ:LVTX
|
Average P/S:
3 333 161.7
4.5
|
N/A | N/A | |
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
36 662 780
|
N/A | N/A |
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
6.6
|
8%
|
0.8 |
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
5
|
4%
|
1.3 |
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
4.9
|
3%
|
1.6 |
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
11.3
|
10%
|
1.1 |
|
US |
E
|
Epizyme Inc
F:EPE
|
1 921.5
|
N/A | N/A |
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
5
|
7%
|
0.7 |
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
4.9
|
7%
|
0.7 |
|
US |
S
|
Seagen Inc
F:SGT
|
18.5
|
30%
|
0.6 |
|
NL |
![]() |
argenx SE
XBRU:ARGX
|
16
|
37%
|
0.4 |
|
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.